These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33745094)
1. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma. Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094 [TBL] [Abstract][Full Text] [Related]
2. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma. Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742 [TBL] [Abstract][Full Text] [Related]
3. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma. Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010 [TBL] [Abstract][Full Text] [Related]
4. Influence of Ground Glass Opacity and the Corresponding Pathological Findings on Survival in Patients with Clinical Stage I Non-Small Cell Lung Cancer. Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Tane K; Tsuboi M J Thorac Oncol; 2018 Apr; 13(4):533-542. PubMed ID: 29246833 [TBL] [Abstract][Full Text] [Related]
5. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity. Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278 [TBL] [Abstract][Full Text] [Related]
6. Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: Radiological and pathological assessment of diversity and intratumor heterogeneity. Koezuka S; Mikami T; Tochigi N; Sano A; Azuma Y; Makino T; Otsuka H; Matsumoto K; Shiraga N; Iyoda A Lung Cancer; 2019 Sep; 135():40-46. PubMed ID: 31447001 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer. Hattori A; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K J Thorac Oncol; 2017 Jun; 12(6):954-962. PubMed ID: 28257958 [TBL] [Abstract][Full Text] [Related]
8. Computed tomography features of resected lung adenocarcinomas with spread through air spaces. Toyokawa G; Yamada Y; Tagawa T; Kamitani T; Yamasaki Y; Shimokawa M; Oda Y; Maehara Y J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1670-1676.e4. PubMed ID: 29961590 [TBL] [Abstract][Full Text] [Related]
9. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients. Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875 [TBL] [Abstract][Full Text] [Related]
10. Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Lung Cancer; 2017 Nov; 113():7-13. PubMed ID: 29110852 [TBL] [Abstract][Full Text] [Related]
11. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma? Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638 [TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of consolidation-to-tumor ratio in early lung adenocarcinoma: a retrospective cross-sectional study. Jing W; Liu M; Li W; Li D; Wu Y; Lv F Quant Imaging Med Surg; 2024 May; 14(5):3366-3380. PubMed ID: 38720835 [TBL] [Abstract][Full Text] [Related]
13. Presence of Even a Small Ground-Glass Component in Lung Adenocarcinoma Predicts Better Survival. Berry MF; Gao R; Kunder CA; Backhus L; Khuong A; Kadoch M; Leung A; Shrager J Clin Lung Cancer; 2018 Jan; 19(1):e47-e51. PubMed ID: 28743420 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer. Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):251-260. PubMed ID: 36180013 [TBL] [Abstract][Full Text] [Related]
15. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K Ann Thorac Surg; 2017 Jul; 104(1):313-320. PubMed ID: 28433219 [TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Ground Glass Opacity-Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size. Suzuki S; Sakurai H; Yotsukura M; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI Ann Thorac Surg; 2018 May; 105(5):1499-1506. PubMed ID: 29427615 [TBL] [Abstract][Full Text] [Related]
17. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors. Mimae T; Tsutani Y; Miyata Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M Ann Thorac Surg; 2020 May; 109(5):1530-1536. PubMed ID: 31981497 [TBL] [Abstract][Full Text] [Related]
18. [A Retrospective Study of Mean Computed Tomography Value to Predict the Tumor Invasiveness in AAH and Clinical Stage Ia Lung Cancer]. Wu H; Liu C; Xu M; Xiong R; Xu G; Li C; Xie M Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):190-196. PubMed ID: 29587938 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277 [TBL] [Abstract][Full Text] [Related]
20. Different clinicopathological features between young and older patients with pulmonary adenocarcinoma and ground-glass opacity. Lu X; Chen Y; Li Y; Tang M; Zheng X Sci Rep; 2024 Jul; 14(1):15679. PubMed ID: 38977890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]